All NewsPractice Management
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutWhat’s Your WhEYE?
Conference CoverageConference ListingConference Recaps
Blog
Digital EditionSupplements And Featured PublicationsiTech
Partners
Job BoardSponsored
SubscribeCE
AMD
Allergy
Blepharitis
COVID-19
Cataract
Comanagement
Comprehensive Eye Exams
Conjunctivitis
Contact Lenses
Cornea
DME
Diabetic Eye Disease
Dry Eye
Geographic Atrophy
Glasses
Glaucoma
LASIK
Lens Technology
Lid and Lash
Myopia
Nutrition
OCT
Ocular Surface Disease
Optic Relief
Patient Care
Pediatrics
Presbyopia
Ptosis
Refractive Surgery
Retina
Technology
Therapeutic Cataract & Refractive
Spotlight -
  • Geographic Atrophy
  • Myopia
EyeCare Network
  • Ophthalmology Times

  • Modern Retina

  • Optometry Times

  • Ophthalmology Times Europe

AMD
Allergy
Blepharitis
COVID-19
Cataract
Comanagement
Comprehensive Eye Exams
Conjunctivitis
Contact Lenses
Cornea
DME
Diabetic Eye Disease
Dry Eye
Geographic Atrophy
Glasses
Glaucoma
LASIK
Lens Technology
Lid and Lash
Myopia
Nutrition
OCT
Ocular Surface Disease
Optic Relief
Patient Care
Pediatrics
Presbyopia
Ptosis
Refractive Surgery
Retina
Technology
Therapeutic Cataract & Refractive
EyeCare Network
  • Ophthalmology Times

  • Modern Retina

  • Optometry Times

  • Ophthalmology Times Europe

    • Blog
    • Partners
    • Subscribe
    • CE
Advertisement

Maintain open communication with primary-care physicians

July 5, 2019
By Benjamin P. Casella, OD, FAAO
Publication
Article
Optometry Times JournalVol. 11 No.7
Volume 11
Issue 7

Figure 1: A fundus photograph of the patient’s right posterior pole imaged throu

Figure 1: A fundus photograph of the patient’s right posterior pole imaged through mild cataracts.

Ben Casella

Every three months, I have the opportunity to see a patient who goes way back in the lexicon of our practice. My grandfather stopped practicing about 30 years ago, and he saw this patient in the 1950s. This African-American male, now 78 years old, is a glaucoma patient of mine. His medical history is remarkable for systemic hypertension, for which he takes a daily dose of lisinopril.

Of note, he is functionally monocular, having suffered a severe wound to his left eye as a result of a BB gun when he was a young man. Unfortunately, that eye has no light perception.

Previously by Dr. Casella: Assessing visual crowding and its impact on glaucoma patients 

Patient overview
Over the decade or so that he has been my patient, he has been mostly compliant. He has primary open-angle glaucoma of the right eye, which was diagnosed in the 1980s. He is phakic in that eye with mild nuclear sclerosis, and I currently have his intraocular pressure (IOP) under control with latanoprost (Xalatan, Pfizer) at bedtime and brimonidine (Alphagan, Allergan) 0.15% twice a day.

He last presented for a comprehensive eye examination in April 2019, at which time his IOP was 11 mm Hg in the right eye and 12 mmHg in the left eye by means of Goldmann applanation tonometry at 9:30 a.m.

Related: New technology helps IOP measurement

I have his target pressure set at 10 to12mmHg, as his glaucoma is moderate and because he is functionally monocular. His pretreatment pressures were in the mid-20s in each eye. Entering visual acuity was 20/25 in the right eye and no light perception in the left eye.

He was dilated at this visit, and fundus photography was obtained of his right eye (Figure 1). Severe scarring throughout his left eye precludes accurate optic nerve evaluation and photography.

He has been happy with his vision through his current spectacles for years and understands that he needs them to drive (uncorrected visual acuity is 20/80 in the right eye).

Related: Consider the whole patient when treating glaucoma

Primary care
At the conclusion of the examination, I was walking with him up to the front desk to make a follow-up visit for July when he asked me if I could send the results of his examination to his primary-care physician. I said I’d be happy to.

He told me that, at a recent visit to this doctor, he mentioned that he would be going in for a glaucoma check-up soon, and that the doctor was surprised to learn this. The patient had been seeing this doctor for about a year.

Related: Keep an eye on link between glaucoma and blood pressure

So, I faxed a copy of the examination notes to this doctor and also typed up a short letter explaining that the patient’s glaucoma was well-controlled with latanoprost and brimonidine. I also briefly stated that I am accepting new patients and perform diabetic eye examinations.

Something rare happened after that: The doctor wrote me back!

I received a brief letter stating he had checked to see that we accept Georgia Medicaid, as that was the insurance carrier for most of his patients. He went on to state that he was happy to hear that we see new patients and to look for diabetic referrals from him in the future.

Related: ODs must examine more than just eyes

Open communication
When I thought about this, I realized that I do a good job of sending diabetic eye examination notes to primary-care physicians. I do not utilize a checklist or form; I just hit the high points from the examination, being sure to note visual acuity, IOP and findings indicative of pathology. I make a point to notate the fact that the patient was dilated for his examination.

In addition, I also make a point that I emphasize tight blood glucose control and compliance with the patient’s primary-care physician as well as when I advise the patient to return for follow-up care (which is one year if no pathology is present).

On the other hand, this brief series of events brought to my attention the fact that I could do a better job of conveying the findings of my glaucoma patients to their respective primary-care physicians. I am going to do a better job of this moving forward.

Related: Primary care optometry in the 21st century 

Granted, a medication review showing medications used to treat certain conditions-such as glaucoma-would give a clue as to one’s condition. However, the onus is on me, as part of a patient’s healthcare team, to convey such findings.

This is especially true in the arena of glaucoma medications because systemic effects are certainly possible. I would also be remiss if I did not mention the fact that communication of findings can be another potential practice builder.

I am interested to hear how you convey examination findings to primary-care physicians. I would expect that most ODs are diligent about conveying the results of a diabetic eye examination, but I suspect that there exists some variability in how we communicate with different diseases and conditions. Please contact us to let us know your typical modus operandi for such tasks.

Read more glaucoma articles here

Download Issue PDF
Articles in this issue

How to build a myopia control practice
How to build a myopia control practice
Scleral contact lenses help manage ocular surface disease
Scleral contact lenses help manage ocular surface disease
Best practices for managing keratoconus patients
Best practices for managing keratoconus patients
Figure 1. Topography of the keratoconic patient in Case 1.
9 simple solutions to 9 complex cases
Practice cooperative management early to avoid later complications
Practice cooperative management early to avoid later complications
Consider the underrated significance of vitamin K2 in eye care
Consider the underrated significance of vitamin K2 in eye care
Figure 1: A fundus photograph of the patient’s right posterior pole imaged throu
Maintain open communication with primary-care physicians
 One steroid drop, one time for allergic response
One steroid drop, one time for allergic response
Donald Korb
Q&A: OD research, the future of dry eye, being a wild man
rubbing eyes in sleepiness
Explore the relationship between dry eye and sleep
 Offer more comfort to contact lens wearers
Offer more comfort to contact lens wearers

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
ARVO 2025: Exploring a conversion factor between 2 OCT devices to monitor glaucoma progression
Matt Jones, OD; Matt Burns; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas' passage of HB 1353 received well by optometrists in the state
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
NOA Midwestern Symposium 2025: Knowing when to refer when post-trabeculectomy complications arise
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
NOA Midwestern Symposium 2025: Hypotony-related complications post trabeculectomy
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
CRU 2025: What eye care providers took home that is current, relevant, and useful
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
CRU 2025: Exploring minimally invasive glaucoma surgeries
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
CRU 2025: Interventional glaucoma as a proactive approach to glaucoma management
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
The effects of switching to latanoprostene bunod in patients with glaucoma
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
What patients should know about eye protection during natural disasters
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Eye care organizations, practices provide vision care amid the Greater Los Angeles wildfires
Related Content
Advertisement
Swept source anterior segment OCT aids in early diagnosis of childhood glaucoma. - Image credit: ©Serhii—stock.adobe.com

Swept-source anterior segment-OCT aids in early diagnosis of childhood glaucoma

Lynda Charters
May 30th 2025
Article
Expanding the treatment arsenal in glaucoma management

Expanding the treatment arsenal in glaucoma management

Melissa Tawa, OD, FAAO;Deborah Ristvedt, DO;Inder Paul Singh, MD;Arsham Sheybani, MD
August 31st 2024
Podcast
Audience watching award ceremony Image credit: AdobeStock/kasto

VSP Vision selected as 2025 US Best Managed Company Gold Standard award winner

Jordana Joy, Associate Editor
May 20th 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Doctor conducting eye exam on patient Image credit: AdobeStock/NDABCREATIVITY

What to keep in mind when diagnosing and treating glaucoma

Benjamin P. Casella, OD, FAAO
May 12th 2025
Article
Two scientists discussing data in lab Image credit: AdobeStock/peopleimages.com

ARVO 2025: Perfuse Therapeutics announces positive results from phase 1/2a trial of PER-001, an intravitreal implant for glaucoma

Jordana Joy, Associate Editor
May 9th 2025
Article
Related Content
Glaucoma
|
Patient Care
Advertisement
Swept source anterior segment OCT aids in early diagnosis of childhood glaucoma. - Image credit: ©Serhii—stock.adobe.com

Swept-source anterior segment-OCT aids in early diagnosis of childhood glaucoma

Lynda Charters
May 30th 2025
Article
Expanding the treatment arsenal in glaucoma management

Expanding the treatment arsenal in glaucoma management

Melissa Tawa, OD, FAAO;Deborah Ristvedt, DO;Inder Paul Singh, MD;Arsham Sheybani, MD
August 31st 2024
Podcast
Audience watching award ceremony Image credit: AdobeStock/kasto

VSP Vision selected as 2025 US Best Managed Company Gold Standard award winner

Jordana Joy, Associate Editor
May 20th 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Doctor conducting eye exam on patient Image credit: AdobeStock/NDABCREATIVITY

What to keep in mind when diagnosing and treating glaucoma

Benjamin P. Casella, OD, FAAO
May 12th 2025
Article
Two scientists discussing data in lab Image credit: AdobeStock/peopleimages.com

ARVO 2025: Perfuse Therapeutics announces positive results from phase 1/2a trial of PER-001, an intravitreal implant for glaucoma

Jordana Joy, Associate Editor
May 9th 2025
Article
Advertisement
Recent Content
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.

CCS 2025: Taking a contemporary approach to dry eye disease with Dr Mitch Ibach

Swept source anterior segment OCT aids in early diagnosis of childhood glaucoma. - Image credit: ©Serhii—stock.adobe.com

Swept-source anterior segment-OCT aids in early diagnosis of childhood glaucoma

Four hands putting together puzzle pieces Image credit: AdobeStock/Johnstocker

Pangaea Data and Topcon Healthcare announce strategic investment

Closeup of dry eye before and after treatment. Image credit: AdobeStock/AlessandroGrandini

Iolyx Therapeutics releases phase 2 results for ILYX-002 in autoimmune-associated dry eye disease

View More Recent Content
Advertisement
Advertisement
x
Advertise
About Us
Editorial
Contact Us
Job Board
Terms & Conditions
Privacy
Do not sell my Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.